Develops stem cell therapies for chronic and degenerative conditions.
Jun 2026Revenue $9.41M/yrExpenses $9.37M/yr
No trend
Figures by year
Is Regenerative Medical Technology Group profitable?
Yes. In the 12 months to Jun 2026, revenue was $9.41M and expenses $9.37M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $5.10M | $5.97M | −$867K |
| Dec 2024 | $4.11M | $4.03M | $81.2K |
| Dec 2023 | $2.41M | $3.13M | −$715K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.